MET

In Q1 2026, MetLife announced adjusted EPS of $2.42, surpassing forecasts but missing revenue expectations, leading to a stock drop. The company increased its common stock dividend by 4.4% to $0.5925 per share, marking 13 years of consecutive growth. MetLife recommended shareholders reject a 'mini-tender' offer by Potemkin Limited. MetLife Investment Management originated $26 billion in private fixed income transactions in 2025. MetLife unveiled its five-year 'New Frontier' growth strategy, aiming for double-digit adjusted EPS growth and a 15-17% adjusted return on equity. The company completed a $10 billion risk transfer of its variable annuity portfolio to Talcott Resolution Life Insurance Company. MetLife's stock has seen a 0.30% change over the past year, with a 52-week range between $67.33 and $83.85.